# Observational Follow-up to ST-001 Calciphylaxis Pain Treatment With Intravenous Sodium Thiosulfate

> **NCT03319914** · — · TERMINATED · sponsor: **Hope Pharmaceuticals** · enrollment: 5 (actual)

## Conditions studied

- Calciphylaxis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03319914
- **Lead sponsor:** Hope Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2017-10-20
- **Primary completion:** 2018-11-09
- **Final completion:** 2018-11-09
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Subjects did not receive Hope Pharmaceuticals' Sodium Thiosulfate Injection.
- **Last updated:** 2018-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03319914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03319914, "Observational Follow-up to ST-001 Calciphylaxis Pain Treatment With Intravenous Sodium Thiosulfate". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03319914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*